Research Peptide Stacks: Co-Formulated Blends vs Multi-Vial Kits Compared

"Stack" is used loosely enough to cover three products that behave completely differently in an experiment. One is a co-lyophilized blend: several peptides in a single vial at a mass ratio fixed at the point of manufacture. The second is a multi-vial kit: the same molecules supplied unmixed, each with its own certificate, to be prepared separately. The third is a starter kit, which is one compound plus the consumables needed to work with it. Choosing between the first two is a methodological decision, not a packaging preference, and the choice is usually settled by one question: does your design need the ratio between components to be a variable?

This guide sets out what each architecture commits you to, why equal masses of two peptides are almost never equal molar amounts, which combinations carry component-specific reconstitution problems, and which research question each of the catalogue's stacks is actually built for. Everything here describes research chemicals for in-vitro and preclinical laboratory work; no combination is described as having an effect, and no protocol guidance is given.

Three architectures, three commitments

Co-lyophilized blends: the ratio is permanent

A blend vial contains the components freeze-dried together. GLOW Blend is 70 mg total at a typical split of GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg; KLOW Blend is the same core plus 10 mg of KPV for 80 mg. The Wolverine blend is BPC-157 and TB-500 co-lyophilized 1:1 at 10 or 20 mg total. BPC-157 + TB-500 + KPV is 30 mg at 10 mg each. TB-500 + GHK-Cu is 60 mg at a 1:5 ratio. GHK-Cu + Epitalon is 60 mg at 5:1. Semax + Selank is 1:1. The growth-hormone blends — CJC-1295 (No DAC) with GHRP-2, the same analogue with GHRP-6, Ipamorelin with GHRP-2, and CJC-1295 DAC with ipamorelin — are all 1:1 by mass, and Tesamorelin + CJC-1295 (No DAC) is 2:1. The Lean Stack is a four-peptide 36 mg vial.

Once those components are in the same cake there is no way to separate them. Changing the ratio means buying a different product, and every concentration you prepare carries the manufacturer's ratio with it. What you gain is a single reconstitution step, one septum entry and no risk of a transfer error between components — which is worth having when the ratio is settled and the study is about something else.

Multi-vial kits: the ratio stays free

A kit supplies the same molecules in separately sealed vials with an individual lot-matched certificate for each. The GH Stack is CJC-1295 no-DAC, ipamorelin and sermorelin. The Neuro Stack is Semax, Selank and Dihexa. The Immune Stack is Thymosin Alpha-1, Thymalin and LL-37. The Repair+ Stack is BPC-157, TB-500 and KPV. The Joint & Tendon Stack adds GHK-Cu and ipamorelin to that repair core, as four vials. The Prime Stack is tesamorelin, ipamorelin and MOTS-c. The Sleep Stack is DSIP, Epitalon and melatonin. The Hair Growth Stack is GHK-Cu, AHK-Cu and PTD-DBM. The Skin & Glow Stack is GHK-Cu, glutathione and Melanotan I. The Metabolic Stack is semaglutide, AOD-9604 and MOTS-c, and the Ascend Stack pairs semaglutide and cagrilintide with a Lipo-C solution.

Three things follow from the vials being separate. The ratio is yours to set, which is the only architecture compatible with a dose–response or factorial design. Each component is individually traceable, so a single failing assay implicates one certificate rather than invalidating a whole vial. And each component can be reconstituted in the vehicle it actually needs, which matters more often than the catalogue copy suggests.

Starter kits: a consumables problem, not a scientific one

The four starter kits solve a different problem entirely. The BPC-157 Research Starter Kit is one 5 mg vial with bacteriostatic water, 31G insulin-style syringes and isopropyl prep pads. The GH Peptide Starter Kit pairs a 10 mg CJC-1295 (No DAC) + Ipamorelin vial with the same consumables. The GLP-1 Research Starter Kit is a 5 mg semaglutide vial with diluent, syringes and pads. The Longevity Starter Kit is a 500 mg NAD+ vial and a 10 mg Epitalon vial with bacteriostatic water and syringes. None of these is a combination in the pharmacological sense; what they bundle is the diluent, the measuring device and the aseptic consumables that a bare vial does not include. Which gauge and volume to want from those syringes is covered in the syringe and needle guide.

Equal mass is not equal moles

This is the single most consequential thing to understand about any peptide combination, and it applies to blends and kits alike. A "1:1" or "10 mg each" label describes mass, and receptors count molecules. Because the peptides in this catalogue span more than an order of magnitude in molecular weight — from KPV at 342.43 g/mol to tesamorelin at 5,135.86 — a mass ratio and a molar ratio can be entirely different numbers.

The Lean Stack makes the point cleanly because three of its four components are loaded identically. Tesamorelin 10 mg, MOTS-c 10 mg and ipamorelin 10 mg are 1.95, 4.60 and 14.05 micromoles respectively — a 7.2-fold molar spread across three figures that read the same on the label. The 6 mg of AOD-9604 adds 3.31 micromoles, which puts it above tesamorelin in molar terms despite being the smallest mass in the vial.

GLOW Blend shows the same effect at the extreme. Its 50:10:10 mass split is 123.8 micromoles of GHK-Cu, 7.04 of BPC-157 and 11.25 of TB-500 — a molar ratio closer to 17.6 : 1 : 1.6 than to the 5:1:1 on the label, because GHK-Cu at 403.93 g/mol is less than a third the mass of BPC-157 at 1,419.55. The full per-component treatment of that vial and its KPV-containing sibling is in the KLOW vs GLOW comparison.

The effect is not universal, and knowing when it disappears is as useful as knowing when it bites. GHK-Cu + Epitalon is labelled 5:1 by mass and works out at 4.83:1 molar, because 403.93 and 390.35 g/mol are nearly the same number. Retatrutide + Cagrilintide is 12.5 mg to 2.5 mg, a 5:1 mass ratio and 4.66:1 molar, for the same reason — 4,731.30 against 4,409.07 g/mol. Tirzepatide + Cagrilintide at 7.5:2.5 is 3:1 by mass and 2.75:1 molar. Where components are close in mass, the label ratio is a usable approximation; where they are not, it is misleading, and the GHRH-plus-secretagogue blends are the worst case in the catalogue: CJC-1295 (No DAC) at 3,367.93 g/mol co-lyophilized 1:1 with GHRP-2 at 817.97 gives 1.48 micromoles of the GHRH analogue against 6.11 of the hexapeptide, a 1:4.1 molar imbalance behind a 1:1 label. Running the numbers takes one division per component; the arithmetic is the same as in the reconstitution maths guide.

Component-specific handling that a shared vial cannot accommodate

Several of the multi-vial kits exist precisely because their components want different treatment, and the specifications say so rather than leaving it implied.

The Immune Stack's LL-37 is a 37-residue cationic antimicrobial peptide and needs low-binding labware; prepared in ordinary polypropylene at low concentration it leaves measurable material on the tube wall, and the loss is not reproducible between tubes. The Pulse Stack's oxytocin carries a 1–6 disulfide bridge, so reducing agents have to stay out of the diluent and any buffer it meets — and oxytocin is the least stable of the three once in solution. The Sleep Stack's melatonin is not a peptide at all and may need a co-solvent, while DSIP and Epitalon dissolve readily in bacteriostatic water; melatonin solutions are also light-sensitive in a way the two peptides are not. The Skin & Glow Stack's glutathione oxidises at the thiol on air exposure and is used at far larger mass than the other two components. The Hair Growth Stack's two copper peptides must not meet acidic media, which strips the copper from the complex.

That last point generalises to every copper-containing blend. GHK-Cu, AHK-Cu and anything built on them put redox-active copper(II) in the formulation, which is why GLOW, KLOW, TB-500 + GHK-Cu and GHK-Cu + Epitalon all show a blue tint in powder and solution — the colour is the coordination indicator, and losing it means losing the complex. Chelating buffers strip copper; so does a low enough pH. It is also why no copper blend in the catalogue contains a methionine- or cysteine-bearing peptide: trace copper catalyses thiol and thioether oxidation, and co-formulating Semax, which carries the only methionine among the short nootropic peptides, with a copper tripeptide would be a formulation decision working against itself. BPC-157, TB-500 and KPV all lack sulfur-containing residues, which is part of why they blend with copper peptides as readily as they do.

A blend vial gives you one vehicle, one pH and one storage temperature for everything inside it. Where the components agree on those three things, that is simplification. Where they do not, a kit is the only format that lets each one have what it needs.

What to ask for on a blend certificate

A blend certificate has to do more work than a single-peptide one, and the thing most often missing is the part that substantiates the label. Per-component purity by HPLC establishes that each input was clean. It does not establish that the vial contains them in the stated ratio — that requires a quantitative assay against reference standards for each component, and a 1:1 or 50:10:10 split with no such assay behind it is a fill claim rather than a measurement. Ask for per-component purity, mass-spectrometric identity for each, and whatever ratio verification exists; where the components are near-isobaric or one is present at a small fraction of the total, ask how the method resolves them. How to read each section is set out in the certificate-of-analysis guide, and the narrower question of when a blend is the right purchase at all is covered in blends versus single vials.

One further documentation note. Several products filed with the blends are not peptide blends: Lipo-B and Lipo-C are lipotropic nutrient solutions of methionine, inositol and choline with vitamin B12, with L-carnitine added in the Lipo-C version; Tri-Immune is zinc, ascorbic acid and reduced glutathione; the Amino Blend is four free amino acids; and SLU-PP-332 + BAM-15 is a two-compound small-molecule capsule. These carry component-level analytical testing rather than peptide HPLC purity, and expecting a ≥ 99% figure on them is expecting the wrong document.

Which stack for which research question

Research areas below are the ones stated on each product's specification. They describe what the material is studied in, not an outcome it produces.

Tissue repair, tendon and matrix models

The Repair+ Stack supplies BPC-157, TB-500 and KPV unmixed for work on cell migration, gastrointestinal and tendon models and NF-κB inflammatory signalling. The Joint & Tendon Stack adds GHK-Cu and ipamorelin as a four-vial set, bringing matrix synthesis and GH-axis signalling into the same design. Where the ratio is already settled, GLOW Blend and KLOW Blend are the single-vial equivalents, and BPC-157 + TB-500 + KPV is the unmixed trio co-formulated at 10 mg each.

Growth-hormone axis

The GH Stack puts two GHRH(1-29) analogues and one selective ghrelin-receptor agonist in one kit — CJC-1295 no-DAC, sermorelin and ipamorelin — which is the natural panel for comparing a native fragment against a substituted analogue at a ratio you control. The Prime Stack swaps in tesamorelin and MOTS-c. On the blend side, Ipamorelin + GHRP-2 pairs two secretagogues at the same receptor, and the CJC-1295 blends with GHRP-2 or GHRP-6 pair a GHRH analogue with a hexapeptide; the differences between those two hexapeptides are set out in the GHRP-2 versus GHRP-6 comparison.

Metabolic and mitochondrial models

The Metabolic Stack is semaglutide, AOD-9604 and MOTS-c as three vials, covering incretin receptor signalling, adipose and lipid models and AMPK work in one kit. The Ascend Stack pairs semaglutide and cagrilintide with a Lipo-C solution. The Lean Stack compresses four peptides into one 36 mg vial, and Retatrutide + Cagrilintide and Tirzepatide + Cagrilintide are the incretin-plus-amylin co-formulations — both worth reconstituting slowly and without agitation, because cagrilintide carries anti-fibrillation substitutions for a reason and amylin analogues aggregate under shear. Two further co-formulations pair an incretin with a cofactor rather than with a second peptide: Semaglutide + Vitamin B12 and Tirzepatide + Vitamin B12 both carry methylcobalamin in the same vial, which adds a photosensitive 1,344.38 g/mol corrinoid to a lyophilized peptide and is why both are specified as protected from light at every stage rather than only once reconstituted.

Cognition, sleep and neuroendocrine work

The Neuro Stack is Semax, Selank and Dihexa in three vials, with the two heptapeptides also available co-lyophilized 1:1; the case for each is in the Semax versus Selank comparison. The Sleep Stack is DSIP, Epitalon and melatonin for EEG architecture and circadian-phase work. The Pulse Stack is PT-141, oxytocin and kisspeptin-10, covering melanocortin, oxytocin-receptor and GPR54 pharmacology.

Immune, dermal and follicle models

The Immune Stack is Thymosin Alpha-1, Thymalin and LL-37 — a defined 28-residue thymic peptide, a thymic polypeptide complex and a human cathelicidin, which is a deliberately heterogeneous set and the reason each needs its own preparation. The Hair Growth Stack is GHK-Cu, AHK-Cu and PTD-DBM for dermal papilla and follicle-cycling work. The Skin & Glow Stack is GHK-Cu, glutathione and Melanotan I, spanning matrix synthesis, thiol redox and MC1R melanogenesis.

Regulatory framing

Every product described here is supplied as a research chemical for in-vitro and preclinical laboratory work only. None is approved as a medicine in the United States or the European Union, and combining research compounds does not change that status. Nothing on this page describes human use or recommends any combination, ratio or quantity.